Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00245154 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

296

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: cediranib maleate
DRUG: paclitaxel
OTHER: placebo

Sponsor

NCIC Clinical Trials Group